stocktools
Offerings // ACTUATE THERAPEUTICS, INC.

ACTU offering history

Every offering-related filing in ACTUATE THERAPEUTICS, INC.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 176 filings back to Oct 8, 2015.

Last executed offering
Nov 28, 2025
424B5 — priced deal (shares or notes)
Last registration (announced)
Sep 2, 2025
S-3 — capacity, not a sale
Executed, last 12 months
3
424B pricings + 8-K 3.02 sales
Registered, last 12 months
1
S-1/S-3/F-series registrations
DateFilingWhat it means
Nov 28, 2025424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Sep 10, 2025424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Sep 9, 2025424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Sep 8, 2025EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Sep 2, 2025S-3 →REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Aug 4, 2025424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Aug 4, 2025EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Jul 25, 2025S-1 →REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
Jun 26, 20258-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Apr 16, 2025424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Apr 16, 2025EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Mar 28, 20258-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Mar 28, 2025S-1 →REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
Aug 13, 2024424B4 →EXECUTEDFinal prospectus — offering priced (typical for IPOs and marketed share deals)
Aug 12, 2024EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Jul 23, 2024S-1/A →REGISTEREDS-1/A registration — capacity to sell shares, not a sale yet
Jul 23, 2024FWP →MARKETINGFree-writing prospectus — offering being marketed
Jul 19, 2024S-1/A →REGISTEREDS-1/A registration — capacity to sell shares, not a sale yet
Jul 19, 2024FWP →MARKETINGFree-writing prospectus — offering being marketed
Jul 16, 2024S-1/A →REGISTEREDS-1/A registration — capacity to sell shares, not a sale yet
Jun 21, 2024S-1/A →REGISTEREDS-1/A registration — capacity to sell shares, not a sale yet
Jun 21, 2024FWP →MARKETINGFree-writing prospectus — offering being marketed
Jun 11, 2024S-1/A →REGISTEREDS-1/A registration — capacity to sell shares, not a sale yet
Jun 11, 2024FWP →MARKETINGFree-writing prospectus — offering being marketed
May 24, 2024S-1 →REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
ACTU offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full ACTU workspace →
ACTU offering FAQ

When did ACTU last execute an offering?

Per SEC filings, ACTUATE THERAPEUTICS, INC.'s most recent priced offering document is a 424B5 filed 2025-11-28. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did ACTU last announce or register an offering?

The most recent registration is a S-3 filed 2025-09-02. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.